Approval · Notice of Compliance 11264 · 2010
CAPTOPRIL: Notice of Compliance 11264
Issued April 20, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11264
- Date
- April 20, 2010
- Company
- Sorres Pharma IncMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Angiotensin converting enzyme inhibitor
- Canadian reference product
- CAPOTEN